$9.7 Million is the total value of ALTEGRIS ADVISORS, L.L.C.'s 7 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 44.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Sell | QQQ US 11/18/16 P113put | $4,155,000 | +69150.0% | 35,000 | -41.7% | 42.84% | +61992.8% | |
AGNPRA | Sell | Allergan plc 5.500000 03/01/2018pfd conv ser a | $1,438,000 | -23.3% | 1,750 | -22.2% | 14.83% | -31.6% |
Sell | NXP SEMICONDUCTOR NVdbcv 1.000%12/0 | $1,178,000 | -13.3% | 1,000,000 | -20.0% | 12.15% | -22.7% | |
Sell | salesforce.com, inc. 0.25% 4/1/2018note 0.250% 4/0 | $897,000 | -44.5% | 750,000 | -40.0% | 9.25% | -50.5% | |
New | AMTRUST FINANCIAL SERVIC 2.75% 12/15/2044note 2.750%12/1 | $863,000 | – | 1,000,000 | +100.0% | 8.90% | – | |
Sell | Palo Alto Networks, Inc. 0% 7/1/2019note 7/0 | $762,000 | -20.3% | 500,000 | -33.3% | 7.86% | -28.9% | |
DYNC | Dynegy Inc 7.000000 07/01/2019unit 07/01/20191 | $405,000 | -24.9% | 5,000 | 0.0% | 4.18% | -33.0% | |
Exit | Albany Molecular Research, Inc. 2.25% 11/15/2018note 2.250%11/1 | $0 | – | -500,000 | -100.0% | -5.92% | – | |
Exit | INFINERA CORPdbcv 1.750% 6/0 | $0 | – | -500,000 | -100.0% | -6.69% | – | |
Exit | DEPOMED INC 2.5% 9/1/2021note 2.500% 9/0 | $0 | – | -1,000,000 | -100.0% | -13.96% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- AqGen Liberty Management I, Inc. #1
- Altegris Holdings II, LLC #2
- AqGen Liberty Holdings, LLC #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-03
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
QQQ US 11/18/16 P113 | 9 | Q3 2016 | 49.0% |
ALBANY MOLECULAR RESH INC | 7 | Q2 2016 | 9.4% |
INFINERA CORPORATION | 7 | Q2 2016 | 12.2% |
VEREIT Inc Convertible 3% Due 8/1/2018 FA1 | 7 | Q3 2015 | 8.8% |
Allergan Public Limited Company Preferred | 6 | Q3 2016 | 21.7% |
VEREIT Inc Convertible 3 3/4% Due 12/15/2020 JD15 | 6 | Q3 2015 | 4.6% |
Salesforce.com Inc Convertible 0 1/4% Due 4/1/2018 AO1 | 5 | Q3 2016 | 18.7% |
Palo Alto Networks, Inc 144A Due 7/1/2019 At Mat | 5 | Q3 2016 | 11.1% |
NXP SEMICONDUCTORS N V | 4 | Q3 2016 | 15.7% |
PRICELINE GRP INC | 4 | Q4 2015 | 9.6% |
View ALTEGRIS ADVISORS, L.L.C.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-NT | 2024-04-02 |
13F-NT | 2024-02-14 |
13F-NT | 2023-11-09 |
13F-NT | 2023-08-10 |
13F-NT | 2023-05-09 |
13F-NT | 2023-02-15 |
13F-NT | 2022-10-28 |
13F-NT | 2022-07-26 |
13F-NT | 2022-05-11 |
13F-NT | 2022-02-04 |
View ALTEGRIS ADVISORS, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.